Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/bjh.16993 http://scihub22266oqcxt.onion/10.1111/bjh.16993 32621757!7362074!32621757     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32621757&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Br+J+Haematol 2020 ; 190 (4): 529-532 Nephropedia Template TP {{tp|p=32621757|t=2020. Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications |pdf=|usr=}}{{32621757}} gab.com Text Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications JO: Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32621757 #FOAvip COVID-19 is associated with increased risk of venous thromboembolic events (VTE). However, there is significant heterogeneity in the thromboembolic phenotypes of COVID-19 patients (deep vein thrombosis, pulmonary embolism/thrombosis). The latter might be partly attributed to the variation in VTE risk factors in COVID-19 patients including: (i) patients' characteristics; (ii) hospitalization conditions and interventions; and (iii) SARS-CoV-2-specific factors (coagulopathy, endothelial injury/microthrombosis). Furthermore, there is methodological heterogeneity in relation to the assessment of VTE (indications for screening, diagnostic methodology, etc). Physicians should be aware of the increased VTE risk, strongly consider VTE screening, and use thromboprophylaxis in all hospitalized patients. Twit Text FOAVip Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications ????Br J Haematol http://www.kidney.de/pget.php?&tw=1&pmid=32621757 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32621757 #FOAvip English Wikipedia <ref>{{Cite pmid|32621757}}</ref> Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications #MMPMID32621757 Kollias A; Kyriakoulis KG; Stergiou GS; Syrigos K Br J Haematol 2020[Aug]; 190 (4): 529-532 PMID32621757show ga COVID-19 is associated with increased risk of venous thromboembolic events (VTE). However, there is significant heterogeneity in the thromboembolic phenotypes of COVID-19 patients (deep vein thrombosis, pulmonary embolism/thrombosis). The latter might be partly attributed to the variation in VTE risk factors in COVID-19 patients including: (i) patients' characteristics; (ii) hospitalization conditions and interventions; and (iii) SARS-CoV-2-specific factors (coagulopathy, endothelial injury/microthrombosis). Furthermore, there is methodological heterogeneity in relation to the assessment of VTE (indications for screening, diagnostic methodology, etc). Physicians should be aware of the increased VTE risk, strongly consider VTE screening, and use thromboprophylaxis in all hospitalized patients. |*COVID-19 Drug Treatment[MESH] |*COVID-19/blood/complications/diagnosis[MESH] |*SARS-CoV-2[MESH] |*Venous Thromboembolism/blood/diagnosis/drug therapy/etiology[MESH] |Anticoagulants/*therapeutic use[MESH] |Humans[MESH]Heterogeneity in reporting venous thromboembolic phenotypes in COVID-1(epmc).pdf DeepDyve Pubget Overpricing